Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.
暂无分享,去创建一个
D. Memmos | E. Alexopoulos | P. Giamalis | L. Gionanlis | A. Belechri | A. Papayianni | P. Koukoudis
[1] P. Stenvinkel,et al. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[3] C. Luley,et al. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. , 1999, Journal of the American College of Cardiology.
[4] B. Heintz,et al. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? , 1999, Clinical nephrology.
[5] L. Gesualdo,et al. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes. , 1998, Kidney international.
[6] M. Reale,et al. Serum Levels of Soluble Adhesion Molecules in Chronic Renal Failure and Dialysis Patients , 1998, Nephron.
[7] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[8] P. Ridker,et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.
[9] E. Boerwinkle,et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.
[10] R. de Caterina,et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[11] H. Vetter,et al. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. , 1997, European journal of medical research.
[12] E. Falleti,et al. Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.
[13] C. Bode,et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[14] E. Falleti,et al. Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. , 1996, Journal of the American Society of Nephrology : JASN.
[15] J. Mehta,et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. , 1996, American heart journal.
[16] H. Rabb,et al. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] T. Akahoshi,et al. In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] H. Sieberth,et al. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure. , 1995, Clinical nephrology.
[19] U. Ikeda,et al. Monocyte chemoattractant protein 1 inhibits growth of rat vascular smooth muscle cells. , 1995, The American journal of physiology.
[20] T. Carlos,et al. Leukocyte-endothelial adhesion molecules. , 1994, Blood.
[21] A. Blann,et al. Circulating Endothelial Cell/Leukocyte Adhesion Molecules in Atherosclerosis , 1994, Thrombosis and Haemostasis.
[22] E. Leonard,et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. , 1993, Human pathology.
[23] S. J. Cashman,et al. Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance , 1992, Annals of the New York Academy of Sciences.
[24] A. Cheung. Biocompatibility of hemodialysis membranes. , 1990, Journal of the American Society of Nephrology : JASN.
[25] T. Luger,et al. Blood-membrane interaction in hemodialysis leads to increased cytokine production. , 1987, Kidney international.
[26] L. Lins,et al. Monocyte and granulocyte CD11b/CD18, CD62L expression and sICAM-1 concentration in the interdialytic period. , 1996, Nephron.